Compare Fox Corp Class A (FOXA) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Neurocrine Biosciences Inc — how do they compare? Fox Corp Class A trades at $62.43 (market cap $24.58B), while Neurocrine Biosciences Inc trades at $156 (market cap $16.46B). The key difference: Fox Corp Class A is the larger of the two by market cap, and Fox Corp Class A pays a 0.93% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| FOXA | NBIX | |
|---|---|---|
Market Cap | $24.58B | $16.46B |
Sector | Media | Health |
52-Week High | $76.11 | $185.50 |
52-Week Low | $48.79 | $123.10 |
Enterprise Value | $27.94B | $16.48B |
Dividend Yield | 0.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
